Rationale and design of a randomized double-blind trial to study the benefit of colchicine in patients with acutely decompensated heart failure: COLICA trial.

Back

HFA Premium Access

Rationale and design of a randomized double-blind trial to study the benefit of colchicine in patients with acutely decompensated heart failure: COLICA trial.

Session: ePosters in acute heart failure 12

Topic: Pharmacotherapy

Speaker: Miss A. Garcia Garcia (Murcia, ES)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Miss Alba Maria Garcia Garcia

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

0 follower

7 more presentations in this session

Temporal trends in guideline-directed medical therapy prescription and 30-day readmission after heart failure hospitalization

Speaker: Doctor R. Laborante (Rome, IT)

Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure

Speaker: Doctor F. Gerardo (Amadora, PT)

Adherence to quadruple therapy for heart failure. A single-center experience in LMIC

Speaker: Doctor A. Khan (Peshawar, PK)

Impact on hospitalisation and safety of high doses of torasemide in advanced or end-stage decompensated heart failure

Speaker: Doctor T. Castiello (London, GB)

Potential cardio-protective role of dapagliflozin in diabetic patients presented with anterior ST-elevation myocardial infarction (STEMI).

Speaker: Associate Professor A. Ibrahim (Aswan, EG)

Access the full session

ePosters in acute heart failure 12

Speakers: Miss A. Garcia Garcia, Doctor R. Laborante, Doctor F. Gerardo, Doctor A. Khan, Doctor T. Castiello...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources